Special Reports

Although the somatizing disorders cover a vast array of symptomatic domains across many medical specialties, this article addresses the broad topic conceptually.

The need to integrate psychiatric treatment with somatic care puts psychosomatic medicine in a unique position to focus on older patients who would not otherwise seek specialized treatment.

For severely ill patients, understanding the neurobiological underpinning of assertive coping provides an additional map for rapid assessment, formulation, and intervention to bolster assertive coping.

An overview of select topics in clinical psycho-oncology, including assessment and management of delirium and brain lesions, mood and anxiety disorders, medication adverse effects, and existential death anxiety.

The role of transplant psychiatrists is to assess both transplant and donor candidates to determine capacity to consent to the surgery, recent stressors and coping skills, social supports and availability of caregivers, and whether there are psychological or substance abuse issues that would affect outcomes.

With more and more baby boomers turning 65 every day, there will be an enormous increase in elderly patients needing psychiatric care over the next 20 years.

This article summarizes 5 cases from consultation services at several teaching hospitals. These challenging cases illustrate several points for the consultation/liaison psychiatrist to consider in caring for elderly hospitalized patients.

An in-depth look into the behavioral and psychological symptoms of dementia.

DSM-5 criteria for hoarding disorder necessitate that the hoarding behaviors cause clinically significant impairment in the patient’s ability to function.

Clinicians will likely encounter increasing numbers of older adults with late-life depression. Advances in our understanding of the neurobiology can help inform diagnosis and prognosis.

What to do once treatment-resistant depression is established based on risk factors and exclusion of other conditions? Insights here-and a treatment algorithm.

Because cognitive and negative symptoms have the greatest impact on overall recovery, interdisciplinary strategies that target these symptoms are necessary. This article offers details.

The discovery that a single IV infusion of low-dose (subanesthetic) ketamine exerts rapid antidepressant effects constitutes an expansion in our understanding of the neurobiology of depression and provides new avenues for drug development.

What do you include in your differential diagnosis if you suspect Munchausen syndrome? Take the quiz and learn more.

All psychiatrists must familiarize themselves with relevant reporting statutes and be knowledgeable about what constitutes neglect or abuse.

Maltreatment at an early age casts a very long shadow. Here: a look at the long-term effects of early childhood trauma.

The number of persons affected by elder mistreatment and self-neglect is growing-with consequent increases in morbidity and premature mortality.

Why do you need to know about Munchausen by Proxy? Answers here.

Substantial progress has been made in the development of etiologic models of intimate partner violence and interventions for individuals who assault their intimate partners. These authors provide details.

What is the future of psychiatric assessment and treatment of mood disorders? The articles in this Special Report explore some important aspects and issues.

An update on the diagnosis, causation, and treatment of chronic depressive problems. The focus is on the recently introduced diagnostic category of persistent depressive disorder.

Here: the history of psychotic depression for the Study of the Pharmacotherapy of Psychotic Depression (STOP-PD), a summary its epidemiology, significance, diagnostic complexity, and treatment, as well as case vignettes.

This article reviews the most recent (after 2010) published guidelines on bipolar depression.

Most, if not all, antidepressants can cause bothersome adverse effects. These are described here along with strategies to help patients cope.

An overview of special coverage on advances in the treatment of alcohol use disorders.

Very few heavy drinkers receive treatment and fewer still are prescribed medications with demonstrated efficacy. Here, a summary of current research, key takeaways, and highlights from a study on topiramate treatment for heavy drinkers by the lead author of that study.

In addition to the approval of novel medications for alcohol use disorders, the past several years have been marked by an emphasis on development, standardization, and dissemination of new behavioral therapies, including computer-based interventions.

There is increasing evidence and support for medications for alcohol use disorders to be used in regular clinical practice, and not to be limited to specialty substance abuse settings. Here, special considerations for pharmacological management.

The topics in this Special Report provide a broad picture of the issues psychiatrists face as they take a clear-eyed look at the opportunities and challenges in the emerging health care system.